'I feel normal': health officials eye injectable opioid addiction treatment
Sublocade, an injectable alternative to Suboxone, has been approved by Health Canada after a successful run in the U.S. The treatment is administered once a month and is highly touted by many American physicians. (Source: CBC | Health)
Source: CBC | Health - January 17, 2019 Category: Consumer Health News Tags: News/Canada/British Columbia Source Type: news
Health officials eye injectable addiction treatment that could 'turn the tide of the opioid epidemic'
Sublocade, an injectable alternative to Suboxone, has been approved by Health Canada after a successful run in the U.S. The treatment is administered once a month and is highly touted by many American physicians. (Source: CBC | Health)
Source: CBC | Health - January 17, 2019 Category: Consumer Health News Tags: News/Canada/British Columbia Source Type: news
U.S. doctors have a new opioid addiction treatment in their arsenal — it could be here next
Sublocade, a monthly injectable alternative to the widely used opioid treatment Suboxone, has been approved by Health Canada after a small but so far successful run in the U.S. (Source: CBC | Health)
Source: CBC | Health - January 17, 2019 Category: Consumer Health News Tags: News/Canada/British Columbia Source Type: news
UPMC Health Plan training doctors to treat opioid-abuse disorder
Suboxone is a narcotic that can be used to treat addiction to narcotic pain relievers. But being able to prescribe the medication requires a waiver from the Drug Enforcement Agency. (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - December 21, 2018 Category: American Health Authors: Paul J. Gough Source Type: news
Indivior Plans Cheaper Opioid Addiction Drug if Rivals Launch Copycats Indivior Plans Cheaper Opioid Addiction Drug if Rivals Launch Copycats
Indivior Plc said on Tuesday it could launch a cheaper version of its blockbuster opioid addiction treatment, Suboxone, if rivals release generic versions of the drug.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - December 20, 2018 Category: Consumer Health News Tags: Medscape Today News Source Type: news
Indivior plans cheaper opioid addiction drug if rivals launch copycats
Indivior Plc said on Tuesday it could launch a cheaper version of its blockbuster opioid addiction treatment, Suboxone, if rivals release generic versions of the drug. (Source: Reuters: Health)
Source: Reuters: Health - December 18, 2018 Category: Consumer Health News Tags: healthNews Source Type: news
Indivior plans cheaper opioid addiction drug to keep copycats at bay
Indivior Plc said it will launch a cheaper version of its blockbuster opioid addiction treatment, Suboxone, as it seeks to claw back market share lost to copycat versions of the drug. (Source: Reuters: Health)
Source: Reuters: Health - December 18, 2018 Category: Consumer Health News Tags: healthNews Source Type: news
Buprenorphine-Naloxone Cost-Effective for Opioid Use Disorder
MONDAY, Dec. 17, 2018 -- Buprenorphine-naloxone is cost-effective compared with extended-release naltrexone for treating opioid use disorder, according to a study published online Dec. 18 in the Annals of Internal Medicine.
Sean M. Murphy, Ph.D.,... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - December 17, 2018 Category: Pharmaceuticals Source Type: news
Indivior wins fresh hold on Dr. Reddy's Suboxone copy
Indivior Plc has secured another hold on the launch of a generic competitor to its best-selling opioid addiction drug in the United States, the London-listed company said on Wednesday. (Source: Reuters: Health)
Source: Reuters: Health - December 12, 2018 Category: Consumer Health News Tags: healthNews Source Type: news
Indivior says wins fresh hold on Suboxone copy
Indivior Plc said on Wednesday a U.S. court ruling had put a hold on Indian rival Dr. Reddy's Laboratories launching a generic competitor to the London-listed drugmaker's bestselling opioid addiction treatment. (Source: Reuters: Health)
Source: Reuters: Health - December 12, 2018 Category: Consumer Health News Tags: healthNews Source Type: news
A Promising Way to Help Drug Users Is ‘Severely Lacking’ Around the World, Report Says
Global funding for harm reduction programs is in “crisis,” according to the latest Global State of Harm Reduction report, potentially threatening the effectiveness of HIV, hepatitis and drug overdose relief programs worldwide.
Harm reduction policies and programs are meant to curb the negative effects associated with illicit drug use — such as overdoses and the spread of blood-borne illnesses like HIV and hepatitis C — rather than focusing solely on stopping substance use. Proponents, and plenty of research, suggest these practices can have a sizable impact on public health, and help drug users who ...
Source: TIME: Health - December 11, 2018 Category: Consumer Health News Authors: Jamie Ducharme Tags: Uncategorized healthytime HIV/AIDS public health Source Type: news
The Treatment Gap: This City ’ s Overdose Deaths Have Plunged. Can Others Learn From It?
Dayton, Ohio, had one of the highest overdose death rates in the nation in 2017. The city made many changes, and fatal overdoses are down more than 50 percent from last year. (Source: NYT Health)
Source: NYT Health - November 25, 2018 Category: Consumer Health News Authors: ABBY GOODNOUGH Tags: Drug Abuse and Traffic Opioids and Opiates Addiction (Psychology) Deaths (Fatalities) Buprenorphine (Drug) Fentanyl Medicaid Naloxone (Drug) Dayton (Ohio) carfentanil Source Type: news
Dr. Reddy ’s notches win for generic Suboxone sublingual film
Shares in Dr. Reddy’s Laboratories (NYSE:RDY) shot up yesterday after the U.S. Court of Appeals for the Federal Circuit vacated a previous decision that blocked the company from selling a generic verson of Indivior‘s (LON:INDV) Suboxone buprenorphine and naloxone sublingual film.
Dr. Reddy’s said it plans to resume launch activities for the product, which won FDA approvalin June.
Get the full story at our sister site, Drug Delivery Business News.
The post Dr. Reddy’s notches win for generic Suboxone sublingual film appeared first on MassDevice. (Source: Mass Device)
Source: Mass Device - November 21, 2018 Category: Medical Devices Authors: Sarah Faulkner Tags: Drug-Device Combinations Legal News Pharmaceuticals Wall Street Beat Dr. Reddy's Laboratories indivior Source Type: news
U.S. court allows generic version of Indivior opioid abuse drug
A U.S. appeals court on Tuesday allowed generic drug company Dr. Reddy's Laboratories to sell a copycat version of the Indivior Plc opioid treatment Suboxone Film, sending Indivior's stock price down more than 40 percent. (Source: Reuters: Health)
Source: Reuters: Health - November 20, 2018 Category: Consumer Health News Tags: healthNews Source Type: news
Ohio medical practice reveals expansion plan
BrightView Health has opened an outpatient treatment facility in Chillicothe, and the Cincinnati-based medical practice intends to open similar addiction treatment centers in at least five more Ohio cities.
Founded in 2014 in Norwood and now based in Walnut Hills, BrightView has four Greater Cincinnati locations plus one in Dayton and the new center in Chillicothe.
BrightView, which cares for people battling drug or alcohol addictions, focuses on medication assisted treatment such as Suboxone,… (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - November 19, 2018 Category: American Health Authors: Barrett J. Brunsman Source Type: news
